Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aurora Cannabis Inc. - Common Shares (NQ:ACB)

4.130 -0.040 (-0.96%)
Delayed Quote Updated: 2:56 PM EDT, Oct 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Aurora Cannabis Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
News headline image
Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher ↗
Curaleaf looks eager to buy Aurora Cannabis, and that's helped to drive its value up. 
Via The Motley Fool
Topics Cannabis
News headline image
Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform ↗
Tilray Brands' fiscal Q1 2027 results show beverage revenue up 82% and European medical cannabis growth offsetting weaker Canadian sales, reducing reliance on U.S. federal rescheduling. 
Via MarketBeat
Topics Cannabis
News headline image
Curaleaf’s Higher Aurora Bid Raises the Stakes in Cannabis Consolidation ↗
Curaleaf has raised its hostile bid for Aurora Cannabis to $5 per share as Schedule III tax relief fuels cannabis M&A, with Tilray's Oct. 8 earnings seen as a sector barometer. 
Via MarketBeat
Topics Cannabis ETFs
Cannabis Stocks Aren’t a Recovery Trade: Narrow Leadership Splits Quality and Momentum ↗
Via Chartmill
Topics Cannabis
Small-Cap Cannabis Stocks Surge, but Big-Cap Laggards Reveal a Narrow, Speculative Rally ↗
Via Chartmill
Topics Cannabis
TLRY Stock Gained Over 70% In 5 Days, Retail Optimism Spikes Ahead Of Trump's Marijuana Order ↗
Via Stocktwits
Topics Cannabis Government
News headline image
Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch. ↗
Hostile takeovers are called hostile for a reason, and this one is getting ugly. 
Via The Motley Fool
Topics Cannabis
News headline image
Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid ↗
Curaleaf took a hostile, $4-per-share cash-and-stock tender offer for Aurora Cannabis directly to shareholders after private merger talks stalled, seeking global scale ahead of federal cannabis... 
Via MarketBeat
Topics Cannabis
News headline image
Should You Buy Canopy Growth Stock on the Rebound? ↗
Canopy Growth benefited from growth across all its divisions in the first quarter of fiscal 2027, but does that make it a worthwhile investment? 
Via The Motley Fool
Topics Cannabis
News headline image
Is Aurora Cannabis Stock a Buy as Curaleaf Pushes a Hostile Takeover Bid? ↗
Aurora's turnaround could make Curaleaf's offer look too low. 
Via The Motley Fool
Topics Cannabis
News headline image
The Cannabis M&A Wave Is Here. Curaleaf Proved It. Here's Whether Green Thumb Should Ride It -- or Wait to Be Swept Up. ↗
Green Thumb Industries is in a strong position to acquire other cannabis companies, but will that happen? 
Via The Motley Fool
Topics Cannabis
News headline image
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners. ↗
After a huge gold rush, the marijuana sector stumbled, and now consolidation is gaining momentum. 
Via The Motley Fool
Topics Cannabis
News headline image
Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way? ↗
The U.S. company formally kicked off the bid for its peer across the northern border. 
Via The Motley Fool
Topics Cannabis
News headline image
Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target? ↗
Cannabis consolidation appears to be accelerating. 
Via The Motley Fool
Topics Cannabis
News headline image
Joint Operations: Curaleaf Makes a Play for Aurora Cannabis ↗
Curaleaf's unsolicited $272 million tender offer for Aurora Cannabis targets EU-GMP cultivation capacity, with Aurora's board forming a special committee to evaluate the cash-and-stock bid. 
Via MarketBeat
Topics Cannabis
News headline image
Will Canopy Growth Get Acquired? ↗
Curaleaf is attempting to acquire Canopy Growth's rival, Aurora Cannabis, and there could be more consolidation to come in the industry. 
Via The Motley Fool
Topics Cannabis
News headline image
Is Acquiring Aurora Cannabis a Good Move for Curaleaf? ↗
Aurora Cannabis would expand Curaleaf's international presence, but it hasn't been a strong business in recent years. 
Via The Motley Fool
Topics Cannabis
News headline image
Aurora Cannabis (ACB) Q1 2027 Earnings Call Transcript ↗
German market expansion drove $43M in international medical cannabis revenue amid Canadian pricing pressure. 
Via The Motley Fool
Topics Cannabis Earnings
News headline image
Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here’s What This Means for Investors. ↗
It's appealing directly to the Canadian company's shareholders with a cash-and-stock offer. 
Via The Motley Fool
Topics Cannabis
News headline image
Aurora Cannabis Shareholders Approve Board as Fiscal 2026 Results Beat Outlook ↗
Aurora Cannabis (NASDAQ:ACB) said shareholders approved all items presented at its annual general meeting, including setting the board size at five directors, electing the company’s nominees,... 
Via MarketBeat
Topics Cannabis
News headline image
Aurora Cannabis Q1 Earnings Call Highlights ↗
Aurora Cannabis (NASDAQ:ACB) reported fiscal first-quarter 2027 net revenue of C$67.6 million, as growth in international medical cannabis sales was offset by lower Canadian medical revenue following... 
Via MarketBeat
Topics Cannabis Earnings
News headline image
Aurora (ACB) Q4 2026 Earnings Transcript ↗
Aurora (ACB) Q4 2026 Earnings Transcript 
Via The Motley Fool
Topics Cannabis
News headline image
Aurora Cannabis Q4 Earnings Call Highlights ↗
Aurora Cannabis (NASDAQ:ACB) reported a stronger fiscal 2026 performance than it had forecast, driven by growth in global medical cannabis, while warning that fiscal 2027 will be a “reset year” as... 
Via MarketBeat
Topics Cannabis Earnings
News headline image
The 420 Failure: Here's the Real Reason Tilray Brands Has Been a Horrible Investment Despite Operating in a Legal Marijuana Market ↗
The cannabis stock has lost around 96% of its value over the past five years. 
Via The Motley Fool
Topics Cannabis
News headline image
Tilray Brands Reports Record Q3 2026 Results: A Deep Dive into the $207 Million Revenue Milestone
Tilray Brands (NASDAQ:TLRY) has officially transitioned from a volatile cannabis producer to a diversified global consumer packaged goods (CPG) powerhouse, reporting record-breaking Q3 fiscal 2026... 
Via MarketMinute
Topics Cannabis Earnings Economy
News headline image
Tilray Surges on Record Revenue and Global Expansion Despite Third-Quarter Earnings Miss
In a paradoxical display of market confidence, shares of Tilray Brands (NASDAQ:TLRY) surged over 8% on Wednesday following the release of its fiscal third-quarter 2026 financial results. While the... 
Via MarketMinute
Topics Cannabis Earnings
News headline image
Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom? ↗
Is it finally time to consider this beaten-down stock? 
Via The Motley Fool
Topics Cannabis Government Law Enforcement
News headline image
Aurora Cannabis (ACB) Q3 2026 Earnings Transcript ↗
Aurora Cannabis (ACB) Q3 2026 Earnings Transcript 
Via The Motley Fool
Topics Cannabis
News headline image
Do These 2 Cannabis Stocks Have a Future? ↗
Don't get your hopes up. 
Via The Motley Fool
Topics Cannabis Government Law Enforcement
News headline image
I Was Right: President Trump Will Legalize Marijuana in 2026 ↗
The marijuana business just got a little easier in America -- and maybe a whole lot more profitable. 
Via The Motley Fool
Topics Cannabis Government
< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.